The condition known as febrile neutropenia is a critical concern within the oncology and hematology spheres, impacting a significant proportion of patients undergoing myelosuppressive therapies. Its severe nature demands immediate attention, making the speed of diagnosis and the efficacy of subsequent treatment paramount to patient survival and recovery. This intense clinical requirement for...